PEN/STREP INJECTION

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

Aktif bileşen:

PROCAINE BENZYLPENICILLIN, DIHYDROSTREPTOMYCIN

Mevcut itibaren:

Chem-Pharm

ATC kodu:

QJ01RA01

INN (International Adı):

PROCAINE BENZYLPENICILLIN, DIHYDROSTREPTOMYCIN

Doz:

Unknown

Farmasötik formu:

Suspension for Injection

Reçete türü:

POM

Terapötik grubu:

Bovine, Ovine, Porcine

Terapötik alanı:

Penicillins, combinations with other antibacterials

Terapötik endikasyonlar:

Antibacterial

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

1997-10-01

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
PEN/STREP Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Suspension for injection.
A white to off-white suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle
Sheep
Pigs
Each ml contains:
Active substances
Procaine Benzylpenicillin
200 mg
Dihydrostreptomycin Sulphate
equivalent to Dihydrostreptomycin
200 mg
Excipients
Methyl, ethyl, and propyl parahydroxybenzoates
as sodium salts (as preservative)
1.5 mg
Sodium formaldehyde sulfoxylate (as antioxidant) 1.25 mg
For a full list of excipients, see section 6.1
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 13/05/2011_
_CRN 7005242_
_page number: 1_
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of systemic infections caused by or associated with organisms sensitive to penicillin and/or
streptomycin including:
_Corynebacterium pyogenes_
_Erysipelothrix rhusiopathiae_
_Klebsiella pneumoniae_
_Listeria _spp
_Pasteurella haemolytica_
_Pasteurella multocida_
_Staphylococcus _spp. (non penicillinase producing)
_Streptococcus _spp.
Pen-Strep will therefore be effective in the treatment of infections caused by susceptible organisms including;
erysipelas, navel/joint ill, respiratory tract infections, including pneumonia and atrophic rhinitis, listeriosis, meningitis,
septicaemia, toxaemia associated with mastitis, urogenital tract infections, enteritis and the control of secondary
bacterial invaders in diseases of primary viral origin.
4.3 CONTRAINDICATIONS
Not for intravenous administration
Not for use in sheep producing milk for human consumption.
Contra-indicated in known cases of hypersensitivity to penicillins.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Occasional